Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Respirology. 2019 Jan 29;24(6):543–550. doi: 10.1111/resp.13478

Table 1:

Baseline Demographics of Study Population by BMI group

BMI (kg/m2) < 25 25–29.9 30–39.9 > 40 p
n (female) 37 (24) 23 (14) 39 (29) 17 (13) 0.58
Age (years) 37.4±15.5 36.8±11.8 40.1±14.2 39.6±12.4 0.76
Race 0.002
Caucasian 31 12 16 10
Black 3 9 22 5
Other 3 2 1 2
Age of Asthma Onset (years) 15.9±16.2 12.8±11.6 13.9±13.2 18.8±14.0 0.54
Waist Circumference (cm) 84.7±14.4 91.4±15.3 99.8±13.9 109.5±24.0 < 0.001
FEV1 (% pred) 88.2±13.2 91.2±15.0 88.5±17.1 86.9±12.1 0.82
FVC (% pred) 96.8±13.3 103.5±15.8 97.6±15.5 94.9±12.1 0.22
FEV1/FVC (% pred) 91.4±9.2 88.3±8.7 90.5±8.7 91.9±8.7 0.52
Peak flow (% pred) 85.9±15.3 90.4±18.9 89.5±16.8 77.7±18.1 0.08
PC20 (mg/ml) 4.23±5.37 3.50±5.46 4.26±4.79 3.84±6.08 0.44
ASUI (range 0–1) 0.71±0.20 0.73±0.15 0.73±0.19 0.67±0.19 0.70
ACT (range 5–25) 15.7±2.9 16.1±3.1 15.8±3.2 14.3±3.6 0.33

BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; FEV1/FVC, ratio of FEV1 to FVC; PC20, the provocative concentration of methacholine that induced a 20% fall in FEV1; ASUI, asthma symptom utility index; ACT, asthma control test

Values shown are mean ± SD,

higher score indicative of better health

p value shown for Kruskal Wallis test